يعرض 1 - 10 نتائج من 117 نتيجة بحث عن '"Pigozzo, J"', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma

    المؤلفون: Guida M., Bartolomeo N., Quaresmini D., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Valente M., Sciacovelli A. M., Chiarion Sileni V., Ascierto P. A., Stigliano L., Strippoli S.

    المساهمون: Guida, M., Bartolomeo, N., Quaresmini, D., Quaglino, P., Madonna, G., Pigozzo, J., Di Giacomo, A. M., Minisini, A. M., Tucci, M., Spagnolo, F., Occelli, M., Ridolfi, L., Queirolo, P., De Risi, I., Valente, M., Sciacovelli, A. M., Chiarion Sileni, V., Ascierto, P. A., Stigliano, L., Strippoli, S.

    مصطلحات موضوعية: Checkpoint inhibitor, Metastatic melanoma, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Blood Platelet, Human, Immunotherapy, Lymphocyte, Prognosi, Prospective Studie, Proto-Oncogene Proteins B-raf, Retrospective Studie, Melanoma, Neutrophils

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35382857; info:eu-repo/semantics/altIdentifier/wos/WOS:000778499200004; volume:20; issue:1; firstpage:1; lastpage:15; numberofpages:15; journal:JOURNAL OF TRANSLATIONAL MEDICINE; https://hdl.handle.net/11365/1221041Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85127719534; https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03359-xTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981693Test/

    الإتاحة: https://doi.org/10.1186/s12967-022-03359-xTest
    https://hdl.handle.net/11365/1221041Test
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981693Test/

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel

    المؤلفون: Spada F., Bossi P., Caraco C., Sileni V. C., Dei Tos A. P., Fazio N., Grignani G., Maio M., Quaglino P., Queirolo P., Ascierto P. A., Antonini Cappellini G. C., Antonuzzo L., Badalamenti G., Barberis M., Bassetto F., Berardi R., Berruti A., Bongiovanni A., Bonomo P., Borgognoni L., Borzillo V., Bruder F., Campana D., Consoli F., Cordova A., Depenni R., Di Giacomo A. M., Fabbrocini G., Fargnoli M. C., Ferraresi V., Ferrau F., Fierro M. T., Gatti M., Gelsomino F., Giuffrida D., Graziano P., Gregorelli C., Guida M., Massi D., Mazzarotto R., Milesi L., Minisini A. M., Morgese F., Muto P., Palmieri G., Patuzzo R., Pellacani G., Picciotto F., Pigozzo J., Pimpinelli N., Poletti P., Repetto L., Rinaldi G., Rubegni P., Rubino G., Spagnolo F., Tagliaferri L., Tanda E., Tronconi M. C., Tucci M., Valente M., Vincenzi B., Zalaudek I.

    المساهمون: Spada F., Bossi P., Caraco C., Sileni V.C., Dei Tos A.P., Fazio N., Grignani G., Maio M., Quaglino P., Queirolo P., Ascierto P.A., Antonini Cappellini G.C., Antonuzzo L., Badalamenti G., Barberis M., Bassetto F., Berardi R., Berruti A., Bongiovanni A., Bonomo P., Borgognoni L., Borzillo V., Bruder F., Campana D., Consoli F., Cordova A., Depenni R., Di Giacomo A.M., Fabbrocini G., Fargnoli M.C., Ferraresi V., Ferrau F., Fierro M.T., Gatti M., Gelsomino F., Giuffrida D., Graziano P., Gregorelli C., Guida M., Massi D., Mazzarotto R., Milesi L., Minisini A.M., Morgese F., Muto P., Palmieri G., Patuzzo R., Pellacani G., Picciotto F., Pigozzo J., Pimpinelli N., Poletti P., Repetto L., Rinaldi G., Rubegni P., Rubino G., Spagnolo F., Tagliaferri L., Tanda E., Tronconi M.C., Tucci M., Valente M., Vincenzi B., Zalaudek I.

    مصطلحات موضوعية: immunotherapy, radiotherapy, skin neoplasms

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35701070; info:eu-repo/semantics/altIdentifier/wos/WOS:000811680400001; volume:10; issue:6; firstpage:1; lastpage:14; numberofpages:14; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; https://hdl.handle.net/11585/904590Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85132050226; https://jitc.bmj.com/content/10/6/e004742Test

    الإتاحة: https://doi.org/10.1136/jitc-2022-004742Test
    https://hdl.handle.net/11585/904590Test
    https://jitc.bmj.com/content/10/6/e004742Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    No impact of NRAS mutation on features of primary and metastatic melanoma or on outcomes of checkpoint inhibitor immunotherapy: An italian melanoma intergroup (IMI) study

    المؤلفون: Guida M., Bartolomeo N., Quaglino P., Madonna G., Pigozzo J., Di Giacomo A. M., Minisini A. M., Tucci M., Spagnolo F., Occelli M., Ridolfi L., Queirolo P., De Risi I., Quaresmini D., Gambale E., Sileni V. C., Ascierto P. A., Stigliano L., Strippoli S.

    المساهمون: Guida, M., Bartolomeo, N., Quaglino, P., Madonna, G., Pigozzo, J., Di Giacomo, A. M., Minisini, A. M., Tucci, M., Spagnolo, F., Occelli, M., Ridolfi, L., Queirolo, P., De Risi, I., Quaresmini, D., Gambale, E., Sileni, V. C., Ascierto, P. A., Stigliano, L., Strippoli, S.

    مصطلحات موضوعية: Checkpoint inhibitor, Immunotherapy, Melanoma, NRAS mutation

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33530579; info:eu-repo/semantics/altIdentifier/wos/WOS:000615004300001; volume:13; issue:3; firstpage:1; lastpage:15; numberofpages:15; journal:CANCERS; https://hdl.handle.net/11365/1233247Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85099938582; https://www.mdpi.com/2072-6694/13/3/475Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865301Test/

    الإتاحة: https://doi.org/10.3390/cancers13030475Test
    https://hdl.handle.net/11365/1233247Test
    https://www.mdpi.com/2072-6694/13/3/475Test
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865301Test/

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143)

    المؤلفون: Rastrelli M., Del Fiore P., Russo I., Tartaglia J., Dal Monico A., Cappellesso R., Nicole L., Piccin L., Fabozzi A., Biffoli B., Di Prata C., Ferrazzi B., Dall'Olmo L., Vecchiato A., Spina R., Russano F., Bezzon E., Cingarlini S., Mazzarotto R., Parisi A., Scarzello G., Pigozzo J., Brambullo T., Tropea S., Vindigni V., Bassetto F., Bertin D., Gregianin M., Dei Tos A. P., Cavallin F., Alaibac M., Chiarion-Sileni V., Mocellin S.

    المساهمون: Rastrelli, M., Del Fiore, P., Russo, I., Tartaglia, J., Dal Monico, A., Cappellesso, R., Nicole, L., Piccin, L., Fabozzi, A., Biffoli, B., Di Prata, C., Ferrazzi, B., Dall'Olmo, L., Vecchiato, A., Spina, R., Russano, F., Bezzon, E., Cingarlini, S., Mazzarotto, R., Parisi, A., Scarzello, G., Pigozzo, J., Brambullo, T., Tropea, S., Vindigni, V., Bassetto, F., Bertin, D., Gregianin, M., Dei Tos, A. P., Cavallin, F., Alaibac, M., Chiarion-Sileni, V., Mocellin, S.

    مصطلحات موضوعية: Merkel carcinoma, Merkel cell cancer, Merkel treatment strategie, non-melanoma skin cancer (NMSC), skin cancer

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34976795; info:eu-repo/semantics/altIdentifier/wos/WOS:000738466200001; volume:11; firstpage:737842; numberofpages:10; journal:FRONTIERS IN ONCOLOGY; http://hdl.handle.net/11577/3410860Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85122104340; https://zenodo.org/record/5833513#.YdwgsVnSKUkTest

    الإتاحة: https://doi.org/10.3389/fonc.2021.737842Test
    http://hdl.handle.net/11577/3410860Test
    https://zenodo.org/record/5833513#.YdwgsVnSKUkTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study

    المؤلفون: Gogas, H., Dréno, B., Larkin, J., Demidov, L., Stroyakovskiy, D., Eroglu, Z., Francesco Ferrucci, P., Pigozzo, J., Rutkowski, P., Mackiewicz, J., Rooney, I., Voulgari, A., Troutman, S., Pitcher, B., Guo, Y., Yan, Y., Castro, M., Mulla, S., Flaherty, K., Arance, A.

    المساهمون: F. Hoffmann-La Roche, Genentech Inc

    المصدر: Annals of Oncology ; volume 32, issue 3, page 384-394 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016Test/j.annonc.2020.12.004
    https://api.elsevier.com/content/article/PII:S092375342043203X?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S092375342043203X?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup

    المؤلفون: Rubatto M., Fava P., Stanganelli I., Ribero S., Pigozzo J., Di Giacomo A. M., Ridolfi L., Tronconi M. C., Trojaniello C., Bersanelli M., Garutti M., Indini A., De Risi I., De Tursi M., Merelli B., Morgese F., Occelli M., Cappellini G. C. A., Poletto S., Fedele D., Brugnara S., Frisinghelli M., Formisano L., Conca R., Tucci M., Russillo M., Ceroni L., Queirolo P., Targato G., Strippoli S., Mandala' M., Guida M., Quaglino P.

    المساهمون: Rubatto, M., Fava, P., Stanganelli, I., Ribero, S., Pigozzo, J., Di Giacomo, A. M., Ridolfi, L., Tronconi, M. C., Trojaniello, C., Bersanelli, M., Garutti, M., Indini, A., De Risi, I., De Tursi, M., Merelli, B., Morgese, F., Occelli, M., Cappellini, G. C. A., Poletto, S., Fedele, D., Brugnara, S., Frisinghelli, M., Formisano, L., Conca, R., Tucci, M., Russillo, M., Ceroni, L., Queirolo, P., Targato, G., Strippoli, S., Mandala', M., Guida, M., Quaglino, P.

    مصطلحات موضوعية: Discontinuation of immunotherapy, Metastatic melanoma therapy, Real-life study

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37099946; info:eu-repo/semantics/altIdentifier/wos/WOS:000994560100001; volume:187; firstpage:25; lastpage:35; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11391/1566840Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85153403676

    الإتاحة: https://doi.org/10.1016Test/j.ejca.2023.03.020
    https://hdl.handle.net/11391/1566840Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    1107P Clinical outcomes to checkpoint inhibitors in NRAS mutated metastatic melanoma (MM) compared with wild type BRAF/NRAS: An Italian Melanoma Intergroup (IMI) study

    المؤلفون: Guida, M., Quaglino, P., Pigozzo, J., Gabriele, M., Di Giacomo, A.M., Minisini, A.M., Tucci, M.G., Queirolo, P., Spagnolo, F., Occelli, M., Ridolfi, L., Quaresmini, D., De Risi, I., Strippoli, S.

    المصدر: Annals of Oncology ; volume 31, page S748 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016Test/j.annonc.2020.08.1230
    https://api.elsevier.com/content/article/PII:S0923753420412268?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420412268?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Combination treatment with cobimetinib (C) and atezolizumab (A) vs pembrolizumab (P) in previously untreated patients (pts) with BRAFV600 wild type (wt) advanced melanoma: Primary analysis from the phase III IMspire170 trial

    المؤلفون: Arance, A.M., Gogas, H., Dreno, B., Flaherty, K.T., Demidov, L., Stroyakovskiy, D., Eroglu, Z., Ferrucci, P.F., Pigozzo, J., Rutkowski, P., Mackiewicz, J., Rooney, I., Voulgari, A., Troutman, S., Pitcher, B., Yan, Y., Larkin, J.M.G.

    المصدر: Annals of Oncology ; volume 30, page v906 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdz394.066Test
    https://api.elsevier.com/content/article/PII:S0923753419604266?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419604266?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/30/Supplement_5/mdz394.066/30082438/mdz394.066.pdfTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy

    المؤلفون: Damuzzo, V, Russi, A, Chiumente, M, Masini, C, Rebesco, B, Gregis, F, Nozza, S, Pigozzo, J, Chiarion-Sileni, V, Palozzo, AC

    المصدر: Journal of Oncology Pharmacy Practice ; volume 25, issue 4, page 787-792 ; ISSN 1078-1552 1477-092X

    مصطلحات موضوعية: Pharmacology (medical), Oncology

    الإتاحة: https://doi.org/10.1177/1078155218755867Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab

    المؤلفون: Ferrucci, P.F., Ascierto, P.A., Pigozzo, J., Del Vecchio, M., Maio, M., Antonini Cappellini, G.C., Guidoboni, M., Queirolo, P., Savoia, P., Mandalà, M., Simeone, E., Valpione, S., Altomonte, M., Spagnolo, F., Cocorocchio, E., Gandini, S., Giannarelli, D., Martinoli, C.

    المصدر: Annals of Oncology ; volume 29, issue 2, page 524 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdx059Test
    https://api.elsevier.com/content/article/PII:S0923753419350306?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419350306?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/29/2/524/23980078/mdx059.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث